long intergenic non-protein coding RNA 2637Genealiases: []
Q-omics provides the consensus-scored LINC02637 profile across patient tissues and cancer cell-line models. LINC02637 expression is associated with patient survival in 26 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, LINC02637 is differentially expressed in 10, with the highest sampling consensus in KICH. Additionally, LINC02637 RNA expression shows 16,010 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight UCS, KICH, and ACC as cancer lineages where LINC02637 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02637 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02637 survival associations across molecular data types. LINC02637 RNA expression shows survival associations in the most cancer types (26). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02637 RNA expression–survival associations across cancer types. High LINC02637 expression shows unfavorable associations in HNSC, STAD and COAD, but favorable associations in UCS, UVM and SKCM. The UCS Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCS as the clearest survival context for LINC02637 RNA expression.
This table summarizes LINC02637 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02637. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02637 shows lower tumor expression in KICH, THCA, CHOL, KIRC and LUAD and higher tumor expression in HNSC. The KICH box plot shows higher LINC02637 RNA expression in normal versus tumor tissue (log2 FC = −1.676, t-test p < 0.001).
This table shows molecular features associated with LINC02637 in patient tissues and cancer cell lines. In patient samples, LINC02637 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
